Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jones

Showing results (1451-1460 of 1,600) with videos related to

Pageof 160
Sort By:
Dalton Transactions (Cambridge, England : 2003)|June 13, 2019
Mono- and ditopic hydroxamate ligands towards discrete and extended network architecturesMohammed B Fugu, Rebecca J Ellaby, Helen M O'Connor, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Emerging Infectious Diseases|September 29, 2021
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 VaccinationHeather N Grome, Michael Threlkeld, Steve Threlkeld, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2006
Summary of notifiable diseases--United States, 2004, Ruth Ann Jajosky, Patsy A Hall, et al.
Physics in Medicine and Biology|September 29, 2000
Physical characteristics of the ECAT EXACT3D positron tomographT J Spinks, T Jones, P M Bloomfield, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancerDavid R Spigel, John D Hainsworth, Jitendra G Gandhi, et al.
Investigational New Drugs|November 9, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinibGrace K Dy, Jeffrey R Infante, S Gail Eckhardt, et al.
Eneuro|June 26, 2023
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing CellsFranciely Paliarin, Chelsea Duplantis, Andrea F Jones, et al.
Clinical and Translational Science|June 23, 2015
Strategies to Build Trust and Recruit African American and Latino Community Residents for Health Research: A Cohort StudyIbrahima C Sankaré, Rachelle Bross, Arleen F Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancerIan E Krop, Muralidhar Beeram, Shanu Modi, et al.
Pageof 160

Showing results (1451-1460 of 1,600) with videos related to

Sort By:
Pageof 160
Dalton Transactions (Cambridge, England : 2003)|June 13, 2019
Mono- and ditopic hydroxamate ligands towards discrete and extended network architecturesMohammed B Fugu, Rebecca J Ellaby, Helen M O'Connor, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Emerging Infectious Diseases|September 29, 2021
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 VaccinationHeather N Grome, Michael Threlkeld, Steve Threlkeld, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2006
Summary of notifiable diseases--United States, 2004, Ruth Ann Jajosky, Patsy A Hall, et al.
Physics in Medicine and Biology|September 29, 2000
Physical characteristics of the ECAT EXACT3D positron tomographT J Spinks, T Jones, P M Bloomfield, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancerDavid R Spigel, John D Hainsworth, Jitendra G Gandhi, et al.
Investigational New Drugs|November 9, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinibGrace K Dy, Jeffrey R Infante, S Gail Eckhardt, et al.
Eneuro|June 26, 2023
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing CellsFranciely Paliarin, Chelsea Duplantis, Andrea F Jones, et al.
Clinical and Translational Science|June 23, 2015
Strategies to Build Trust and Recruit African American and Latino Community Residents for Health Research: A Cohort StudyIbrahima C Sankaré, Rachelle Bross, Arleen F Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancerIan E Krop, Muralidhar Beeram, Shanu Modi, et al.
Pageof 160